While Canada engages in complex dialogue about how best to regulate the sale of cannabis for adult use, tens of thousands of Canadians are currently authorized to use cannabis to treat a variety of symptoms and medical conditions.
On February 9, the FDA sent out a number of warning letters to companies that make and sell products containing cannabidiol (CBD), a type of cannabinoid found in marijuana.
The largest clinical trial of its kind, testing medicinal cannabis to treat chemotherapy patients suffering from nausea, has been announced by New South Wales Premier Mike Baird.
Canada’s licensed pot producers are pushing Ottawa to exempt patients from paying any sales tax on their products, which would give medical marijuana the same tax status as prescription drugs.